Press release
Insomnia Treatment Market to Hit US$ 11.39 Billion by 2034, Growing at a CAGR of 5.2%
The global insomnia treatment market is expected to be worth US$ 6,886.1 million in 2024. The market is anticipated to expand at a CAGR of 5.2% from 2024 to 2034. The market is predicted to reach US$ 11,385.5 million in 2034. Increasing awareness and understanding of the condition among patients and healthcare professionals is one of the key drivers of the insomnia treatment industry.As more people come to recognize the impact that insomnia has on their daily lives, they are seeking out treatments to help manage their symptoms. Additionally, advances in medical research and technology have led to the development of more effective and targeted treatments for insomnia. This has allowed healthcare providers to offer patients a wider range of options for managing their condition, from medication to behavioral therapies.
The changes in lifestyle and work patterns have contributed to the rise of insomnia, as many people find themselves struggling to balance their responsibilities with the need for restful sleep. As such, there is a growing need for effective and accessible treatments to help people manage their insomnia and improve their overall quality of life.
For More Insights into the Market, Request a Sample of this Report:https://www.factmr.com/connectus/sample?flag=S&rep_id=9613
Key Market Drivers
Rising Prevalence of Sleep Disorders: Lifestyle changes, increased stress levels, and work-related pressures have contributed to a surge in insomnia cases globally. As more individuals recognize the importance of quality sleep, the demand for treatment options has escalated .
Advancements in Therapeutic Options: The development of novel pharmacological treatments, such as dual orexin receptor antagonists, offers more targeted and effective solutions for insomnia with fewer side effects compared to traditional sedatives .
Growth of Over-the-Counter (OTC) Medications: OTC drugs are gaining popularity due to their accessibility and cost-effectiveness. In 2024, OTC drugs are expected to account for a significant share of the market, driven by consumer preference for easily obtainable sleep aids .
Regional Insights
North America: This region holds a substantial share of the insomnia treatment market, attributed to high awareness levels, robust healthcare infrastructure, and the adoption of digital health tools. The U.S., in particular, faces a significant economic burden due to inadequate sleep, emphasizing the need for effective treatment options .
Asia-Pacific: Countries like India, China, and Japan are experiencing rapid growth in the insomnia treatment market. Factors such as urbanization, increased screen time, and rising mental health concerns contribute to this trend. In India, for instance, the market is expected to grow at a CAGR of 2.57% from 2025 to 2033, driven by increased stress levels and growing awareness about sleep disorders .
Emerging Trends
Digital Therapeutics: The integration of digital solutions, such as mobile applications and wearable devices, is revolutionizing insomnia treatment. These tools offer personalized therapy options, including cognitive behavioral therapy for insomnia (CBT-I), and have shown a 70% success rate in improving sleep quality
Non-Pharmacological Treatments: There's a growing preference for non-drug therapies, including CBT and relaxation techniques, due to concerns over the side effects of long-term medication use. These approaches are gaining traction as effective alternatives for managing insomnia .
Challenges
Despite the positive outlook, the market faces challenges such as side effects associated with certain insomnia medications, which can hamper long-term treatment adherence. Additionally, the need for more personalized treatment approaches remains a critical area for development.
Get Customization on this Report for Specific Research Solutions-https://www.factmr.com/connectus/sample?flag=S&rep_id=9613
Conclusion
The insomnia treatment market is undergoing significant transformation, driven by increased awareness, technological advancements, and a shift towards personalized and non-pharmacological therapies. As the understanding of sleep disorders deepens, the market is expected to continue its growth trajectory, offering diverse and effective treatment options for individuals worldwide.
Explore More Related Studies Published by Fact.MR Research:
Dental Infection Control Products Market
https://www.factmr.com/report/5378/dental-infection-control-products-market
Air Ambulance Services Market
https://www.factmr.com/report/air-ambulance-services-market
Neonatal Ventilator Market
https://www.factmr.com/report/758/neonatal-ventilator-market
Dental 3D Printing Market
https://www.factmr.com/report/4361/dental-3d-printing-market
Joint Reconstruction Devices Market
https://www.factmr.com/report/joint-reconstruction-devices-market
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
About Fact.MR:
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insomnia Treatment Market to Hit US$ 11.39 Billion by 2034, Growing at a CAGR of 5.2% here
News-ID: 4033872 • Views: …
More Releases from FactMR

Biobanking Market to Surge USD 147.9 Billion by 2035, Reshaping Global Research …
The biobanking industry stands at the threshold of a decade-long expansion trajectory that promises to reshape biological sample storage and research infrastructure technology. The market's journey from USD 68.5 billion in 2025 to USD 147.9 billion by 2035 This expansion underscores the industry's pivotal role in modernizing biological sample storage and advancing research infrastructure for pharmaceutical and biotechnology applications.
Biobanking's critical contribution to personalized medicine, drug discovery, and disease research positions…

Biopharmaceutical Packaging Market Set to Soar USD 58.2 Billion by 2035 - Unveil …
The global Biopharmaceutical Packaging Market is entering a decade of unprecedented expansion, set to nearly double in size from USD 28.5 billion in 2025 to USD 58.2 billion by 2035, registering a robust CAGR of 7.4%. This remarkable growth reflects the rising demand for advanced pharmaceutical packaging systems that enhance sterility, improve drug safety, and streamline regulatory compliance.
The market's trajectory is not just about scaling revenue but also about reshaping…

3D Printing in Healthcare Set to Redefine Medical Manufacturing - Market Forecas …
The 3D printing in healthcare industry stands at the threshold of a decade-long expansion trajectory that promises to reshape medical manufacturing and personalized healthcare technology. The market's journey from USD 4.2 billion in 2025 to USD 18.8 billion by 2035This remarkable growth underscores the technology's pivotal role in advancing personalized medicine, surgical precision, and medical device manufacturing, making it an investment priority for forward-looking manufacturers and healthcare technology leaders.Driven by…

Surgical Navigation Glasses Market to Skyrocket USD 6,793 Million by 2035, Growi …
The global surgical navigation glasses market is expected to reach USD 6,793 Million by 2035, up from estimated value of USD 423.0 Million in 2025. During the forecast period 2025 to 2035, the industry is projected to expand at a CAGR of 32.0%.This exponential trajectory underscores the industry's pivotal role in transforming modern surgical practices, particularly in neurosurgery, orthopedics, and minimally invasive procedures.
Fueled by the rapid adoption of Augmented Reality…
More Releases for OTC
Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact…
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain adidas AG officers and…
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE
Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services.
The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology…
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,…
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market.
The…
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF).
Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to…